{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:42:47Z","timestamp":1793065367125,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T00:00:00Z","timestamp":1576454400000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In this retrospective study the relationship between intraocular pressure (IOP), retinal nerve fiber layer (RNFL) thickness and pathologic hypersignal in optic nerve segments on 3D double inversion recovery (DIR) MR sequence in 21 patients with proven glaucoma of different origin was evaluated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>All patients were examined on a 3\u2009T MR Philips\u00ae scanner. Pathologic optic nerve DIR hypersignal was determined in four different nerve segments. IOP was measured in mmHg by applanation tonometry. RNFL thickness was measured in \u03bcm with optical coherence tomography (OCT Heidelberg Engineering Spectralis\u00ae apparatus). Wilcoxon rank sum tests, student\u2019s t-tests and (multivariate) linear regression models were appied.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>3D DIR hypersignal was present in 17 (41.5%) optic nerves. 3D DIR hypersignal was not related to ischemic or demyelinating optic nerve pathology but was associated with increased IOP (19.8 [24\u201318]; versus 15.45; [18.85\u201313.75] mmHg; <jats:italic>p<\/jats:italic>\u2009=\u20090.008) and decreased RNFL thickness (61.06\u2009\u00b1\u200912.1 versus 82.5\u2009\u00b1\u200921.6\u2009\u03bcm; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) in comparison to optic nerves of glaucoma patients without DIR hypersignal. Specifically, presence of DIR hypersignal in optic nerves in at least one optic nerve segment lowered RNFL thickness on average by 17.54\u2009\u03bcm (<jats:italic>p<\/jats:italic>\u2009=\u20090.005) in comparison to optic nerves without DIR hypersignal.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In patients with glaucomatous optic neuropathy (GON) and pathologic optic nerve DIR hypersignal, significantly increased IOP and significantly decreased RNFL thickness values are present. DIR hypersignal seems to be a marker for disease severity in GON related to decreased RNFL thickness and may thus represent long-segment severe axonal degeneration in optic nerves in patients with GON. Venous congestion and edema within the optic nerve related to high IOP may contribute to the DIR hypersignal as well.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-019-1273-0","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T19:03:26Z","timestamp":1576523006000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Long segment 3D double inversion recovery (DIR) hypersignal on MRI in glaucomatous optic neuropathy"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4812-987X","authenticated-orcid":false,"given":"Thomas","family":"Sartoretti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"St\u00fcrmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Sartoretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1rp\u00e1d","family":"Schwenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wyss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Binkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Sartoretti-Schefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,16]]},"reference":[{"issue":"3","key":"1273_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jcjo.2012.02.003","volume":"47","author":"C Cook","year":"2012","unstructured":"Cook C, Foster P. Epidemiology of glaucoma: what\u2019s new? Can J Ophthalmol. 2012;47(3):223\u20136. https:\/\/doi.org\/10.1016\/j.jcjo.2012.02.003.","journal-title":"Can J Ophthalmol"},{"issue":"4","key":"1273_CR2","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S0161-6420(02)01974-7","volume":"110","author":"PP Chen","year":"2003","unstructured":"Chen PP. Blindness in patients with treated open-angle glaucoma. Ophthalmology. 2003;110(4):726\u201333.","journal-title":"Ophthalmology"},{"issue":"4","key":"1273_CR3","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.ajo.2013.05.027","volume":"156","author":"D Peters","year":"2013","unstructured":"Peters D, Bengtsson B, Heijl A. Lifetime risk of blindness in open-angle glaucoma. Am J Ophthalmol. 2013;156(4):724\u201330. https:\/\/doi.org\/10.1016\/j.ajo.2013.05.027.","journal-title":"Am J Ophthalmol"},{"issue":"9422","key":"1273_CR4","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/S0140-6736(04)16257-0","volume":"363","author":"RN Weinreb","year":"2004","unstructured":"Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363(9422):1711\u201320.","journal-title":"Lancet"},{"issue":"1","key":"1273_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S1350-9462(98)00014-7","volume":"18","author":"HA Quigley","year":"1999","unstructured":"Quigley HA. Neuronal death in glaucoma. Prog Retin Eye Res. 1999;18(1):39\u201357.","journal-title":"Prog Retin Eye Res"},{"issue":"9774","key":"1273_CR6","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/S0140-6736(10)61423-7","volume":"377","author":"HA Quigley","year":"2011","unstructured":"Quigley HA. Glaucoma Lancet. 2011;377(9774):1367\u201377. https:\/\/doi.org\/10.1016\/S0140-6736(10)61423-7.","journal-title":"Glaucoma Lancet"},{"issue":"4","key":"1273_CR7","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1001\/archopht.1981.03930010635009","volume":"99","author":"HA Quigley","year":"1981","unstructured":"Quigley HA, Addickes EM, Green WR, Maumenee AE. Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch Ophthalmol. 1981;99(4):635\u201349.","journal-title":"Arch Ophthalmol"},{"key":"1273_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.exer.2017.02.006","volume":"157","author":"ER Tamm","year":"2017","unstructured":"Tamm ER, Ethier CR. Lasker\/IRRFInitiative on astrocytes and glaucomatous Neurodegeneration participants. Biological aspects of axonal damage in glaucoma: a brief review. Exp Eye Res. 2017;157:5\u201312.","journal-title":"Exp Eye Res"},{"key":"1273_CR9","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1097\/IJG.0b013e3182934a0f","volume":"22","author":"HE Killer","year":"2013","unstructured":"Killer HE. Compartment syndromes of the optic nerve and open-angle Glaucoma. J Glaucoma. 2013;22:S19\u201320.","journal-title":"J Glaucoma"},{"issue":"5","key":"1273_CR10","doi-asserted-by":"publisher","first-page":"e472","DOI":"10.1111\/j.1755-3768.2011.02182.x","volume":"89","author":"HE Killer","year":"2011","unstructured":"Killer HE, Jaggi GP, Miller NR. Optic nerve compartment syndrome. Acta Ophthalmol. 2011;89(5):e472.","journal-title":"Acta Ophthalmol"},{"key":"1273_CR11","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/brain\/awl045","volume":"129","author":"HE Killer","year":"2006","unstructured":"Killer HE, Jaggi GP, Flammer J, Miller NR, Huber AR. The optic nerve: a new window into cerebrospinal fluid composition? Brain. 2006;129:1027\u201330.","journal-title":"Brain"},{"key":"1273_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.exer.2017.02.005","volume":"157","author":"C Stowell","year":"2017","unstructured":"Stowell C, Burgoyne CF, Tamm ER, Ethier CR. Lasker\/IRRF initiative on astrocytes and glaucomatous Neurodegeneration participants. Biomechanical aspects of axonal damage in glaucoma: a brief review. Exp Eye Res. 2017;157:13\u20139.","journal-title":"Exp Eye Res"},{"key":"1273_CR13","doi-asserted-by":"publisher","unstructured":"Miglior S (2007) Risk factors for development of Glaucoma. European ophthalmic review. 2007, doi:https:\/\/doi.org\/10.17925\/EOR.2007.00.00.10.","DOI":"10.17925\/EOR.2007.00.00.10"},{"key":"1273_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S1350-9462(02)00008-3","volume":"21","author":"J Flammer","year":"2002","unstructured":"Flammer J, Org\u00fcl S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM, et al. The impact on ocular blood flow on glaucoma. Prog Retin Eye Res. 2002;21:359\u201393.","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"1273_CR15","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1001\/archopht.1995.01100050054031","volume":"113","author":"JS Schuman","year":"1995","unstructured":"Schuman JS, Hee MR, Puliafito CA, Wong C, Pedut-Kloizman T, Lin CP, et al. Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography. Arch Ophthalmol. 1995;113(5):586\u201396.","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"1273_CR16","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ajo.2011.09.032","volume":"153","author":"H Wu","year":"2012","unstructured":"Wu H, de Boer JF, Chen TC. Diagnostic capability of spectral-domain optical coherence tomography for glaucoma. Am J Ophthalmol. 2012;153(5):815\u201326 e812.","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"1273_CR17","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/j.ophtha.2015.06.015","volume":"122","author":"TM Kuang","year":"2015","unstructured":"Kuang TM, Zhang C, Zangwill LM, Weinreb RN, Medeiros FA. Estimating lead time gained by optical coherence tomography in detecting glaucoma before development of visual field defects. Ophthalmology. 2015;122(10):2002\u20139.","journal-title":"Ophthalmology"},{"issue":"13","key":"1273_CR18","doi-asserted-by":"publisher","first-page":"8393","DOI":"10.1167\/iovs.13-12749","volume":"54","author":"JC Mwanza","year":"2013","unstructured":"Mwanza JC, Warren JL, Budenz DL. Ganglion cell analysis study G. combining spectral domain optical coherence tomography structural parameters for the diagnosis of glaucoma with early visual field loss. Invest Ophthalmol Vis Sci. 2013;54(13):8393\u2013400.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"1273_CR19","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1016\/j.ophtha.2016.07.006","volume":"123","author":"A Diniz-Filho","year":"2016","unstructured":"Diniz-Filho A, Abe RY, Zangwill LM, Gracitelli CP, Weinreb RN, Girkin CA, et al. Association between intraocular pressure and rates of retinal nerve Fiber layer loss measured by optical coherence tomography. Ophthalmology. 2016;123(10):2058\u201365.","journal-title":"Ophthalmology"},{"key":"1273_CR20","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1148\/radiol.2361040450","volume":"236","author":"JJ Geurts","year":"2005","unstructured":"Geurts JJ, Pouwels PJ, Uitdehaag BM, Polman CH, Barkhof F, Castelijns JA. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology. 2005;236:254\u201360.","journal-title":"Radiology"},{"key":"1273_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3174\/ajnr.A0594","volume":"28","author":"MP Wattjes","year":"2007","unstructured":"Wattjes MP, Lutterbey GG, Gieseke J, Tr\u00e4ber F, Klotz L, Schmidt S, Schild HH. Double inversion recovery brain imaging at 3T: diagnostic value in the detection of multiple sclerosis lesions. AJNR Am J Neuroradiol. 2007;28:54\u20139.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1273_CR22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17:162\u201373.","journal-title":"Lancet Neurol"},{"issue":"9","key":"1273_CR23","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.3174\/ajnr.A5262","volume":"38","author":"T Sartoretti","year":"2017","unstructured":"Sartoretti T, Sartoretti E, Rauch S, Binkert C, Wyss M, Czell D, Sartoretti-Schefer S. How common is signal-intensity increase in optic nerve segments on 3D double inversion recovery sequences in visually asymptomatic patients with multiple sclerosis? AJNR Am J Neuroradiol. 2017;38(9):1748\u201353.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"1273_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1385\/MN:26:1:045","volume":"26","author":"MB Wax","year":"2002","unstructured":"Wax MB, G\u00fclg\u00fcn T. Neurobiology of glaucomatous optic neuropathy. Diverse cellular events in Neurodegeneration and Neuroprotection. Mol Neurobiol. 2002;26(1):45\u201355.","journal-title":"Mol Neurobiol"},{"key":"1273_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.exer.2017.02.014","volume":"157","author":"PA Williams","year":"2017","unstructured":"Williams PA. Marsh-Armstrong N, Howell GR, Lasker\/IRRF initiative on astrocytes and glaucomatous Neurodegeneration participants. Neuroinflammation in glaucoma: a new opportunity. Exp Eye Res. 2017;157:20\u20137.","journal-title":"Exp Eye Res"},{"key":"1273_CR26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.expneurol.2012.01.014","volume":"246","author":"GR Howell","year":"2013","unstructured":"Howell GR, Soto I, Libby RT, John SW. Intrinsic axonal degeneration pathways are critical for glaucomatous damage. Exp Neurol. 2013;246:54\u201361.","journal-title":"Exp Neurol"},{"issue":"12","key":"1273_CR27","doi-asserted-by":"publisher","first-page":"e114546","DOI":"10.1371\/journal.pone.0114546","volume":"9","author":"CJ Abbott","year":"2014","unstructured":"Abbott CJ, Choe TE, Borgoyne CF, Cull G, Wang L, Fortune B. Comparison of retinal nerve Fiber layer thickness in vivo and axonal transport after chronic intraocular pressure elevation in young versus older rats. PLoS One. 2014;9(12):e114546.","journal-title":"PLoS One"},{"issue":"Suppl. 1","key":"1273_CR28","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/S0039-6257(99)00050-8","volume":"43","author":"HK Chung","year":"1999","unstructured":"Chung HK, Harris A, Evans DW, Kagemann L, Garzozi HJ, Martin B. Vascular aspects in the pathophysiology of glaucomatous optic neuropathy. Surv Ophthalmol. 1999;43(Suppl. 1):S43\u201350.","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"1273_CR29","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00401-011-0807-1","volume":"121","author":"G Chidlow","year":"2011","unstructured":"Chidlow G, Ebneter A, Wood JPM, Casson RJ. The optic nerve head is the site of axonal transport disruption, axonal cytoskeleton damage and putative axonal regeneration failure in a rat model of glaucoma. Acta Neuropathol. 2011;121(6):737\u201351.","journal-title":"Acta Neuropathol"},{"issue":"11","key":"1273_CR30","doi-asserted-by":"publisher","first-page":"5196","DOI":"10.1073\/pnas.0913141107","volume":"107","author":"SD Crish","year":"2010","unstructured":"Crish SD, Sappington RM, Inman DM, Horner PJ, Calkins DJ. Distal axonopathy with structural persistence in glaucomatous neurodegeneration. Proc Natl Acad Sci U S A. 2010;107(11):5196\u2013201.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1273_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.expneurol.2004.03.025","volume":"188","author":"M Bendszus","year":"2004","unstructured":"Bendszus M, Wessig C, Solymosi L, Reiners K, Koltzenburg M. MRI of peripheral nerve degeneration and regeneration: correlation with electrophysiology and histology. Exp Neurol. 2004;188:171\u20137.","journal-title":"Exp Neurol"},{"issue":"6","key":"1273_CR32","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1016\/S0181-5512(08)73678-7","volume":"31","author":"MT Iba-Zizen","year":"2008","unstructured":"Iba-Zizen MT, Istoc A, Cabanis EA. Que penser des resultats d\u2019exploration par IRM des patients atteints de glaucoma? J Fr Ophthalmol. 2008;31(6):2524\u20138.","journal-title":"J Fr Ophthalmol"},{"issue":"3","key":"1273_CR33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/02713683.2017.1399426","volume":"43","author":"JY Lee","year":"2018","unstructured":"Lee JY, Kwon HJ, Park SJ, Yoo C, Kim YY, Kim EY. Signal alteration in the optic nerve head on 3D T2-weighted MRI: a potential neuroimaging sign of glaucomatous optic neuropathy. Curr Eye Res. 2018;43(3):397\u2013405. https:\/\/doi.org\/10.1080\/02713683.2017.1399426.","journal-title":"Curr Eye Res"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-019-1273-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-019-1273-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-019-1273-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T00:19:53Z","timestamp":1607991593000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-019-1273-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1273"],"URL":"https:\/\/doi.org\/10.1186\/s12886-019-1273-0","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"3 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standard of the institutional and \/ or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.This retrospective study with the number Basec 2016\u201301396 was approved by the Institutional Review Board \u201cKantonale Ethikkommision Z\u00fcrich\u201d on 26th September 2016. Additional informed consent and informed consent to publish was waived by the Insitutional Review Board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Additional informed consent and informed consent to publish was waived by the Insitutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MW is a part time employee of Philips Health Systems Switzerland. The authors declare they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"258"}}